SILAC Mass Spectrometry Profiling: A Psychiatric Disorder Perspective.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1007/978-3-319-52479-5_27PMID 28353248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes

  2016cited by this paper
• The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine.

  2016cited by this paper
• Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family

  2016cited by this paper
• SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma Patients

  2015cited by this paper
• Quantitative proteomics using SILAC: Principles, applications, and developments

  2015cited by this paper
• Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression.

  2014cited by this paper
• Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome

  2014cited by this paper
• Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder.

  2014cited by this paper
• Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.

  2014cited by this paper
• Potential biomarkers in psychiatry: focus on the cholesterol system

  2012cited by this paper
• Molecular Sex Differences in Human Serum

  2012cited by this paper
• Psychiatric disorder biomarker discovery using quantitative proteomics.

  2012cited by this paper
• Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia.

  2011cited by this paper
• Advanced Identification of Proteins in Uncharacterized Proteomes by Pulsed in Vivo Stable Isotope Labeling-based Mass Spectrometry*

  2010cited by this paper
• Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics

  2010cited by this paper
• Global analysis of cellular protein translation by pulsed SILAC

  2009cited by this paper
• Antipsychotics in the early stage of development

  2009cited by this paper
• Metabolomic and proteomic analysis of a clonal insulin-producing beta-cell line (INS-1 832/13).

  2008cited by this paper
• Stable isotope labeling by amino acids in cell culture for quantitative proteomics.

  2007cited by this paper
• Impaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia

  2007cited by this paper
• A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)

  2006cited by this paper
• Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.

  2003cited by this paper
• A Proteomic Approach for Identification of Secreted Proteins during the Differentiation of 3T3-L1 Preadipocytes to Adipocytes*

  2002cited by this paper
• Processing of proSAAS in neuroendocrine cell lines.

  2002cited by this paper

• Enhanced Molecular Appreciation of Psychiatric Disorders Through High-Dimensionality Data Acquisition and Analytics.

  2019cites this paper